On this page we presented the JAZZ Historical PE Ratio information for Jazz Pharmaceuticals' stock. The average JAZZ historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 13.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average JAZZ historical PE based on this TTM earnings result method is 12.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this JAZZ historical PE result, against the recent PE: when this page was posted on 10/1/2024, the most recent closing price for JAZZ had been 109.04, and the most recent quarterly earnings result, annualized, was 21.2. Meanwhile, the most recent TTM earnings summed to 17.84. From these numbers, we calculate the recent JAZZ PE on 10/1/2024 based on annualized quarterly EPS was 5.1. Based on JAZZ's history, that recent PE is low relative to the historical average, with the recent PE 62.2% lower than the historical average PE across our data set for Jazz Pharmaceuticals. Looking at the recent JAZZ PE on 10/1/2024 based on TTM EPS, we calculate the ratio at 6.1. Based on JAZZ's history, that recent PE is low relative to the historical average, with the recent PE 52.7% lower than the average PE across our Jazz Pharmaceuticals data set with TTM EPS used in the calculation at each period.

Another interesting JAZZ historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for JAZZ, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for JAZZ, we start with the past four EPS numbers and we first sort them from lowest to highest: 2.68, 4.84, 5.02, and 5.30. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 4.84 and 5.02 — which gives us the median of 4.93. Basically the way to think about this 4.93 number is this: for the trailing four earnings reports, 4.93 marks the "middle ground" number where JAZZ has reported a value higher than 4.93 half the time, and has reported a value lower than 4.93 half the time. Annualizing that median value then gets us to 19.72/share, which we use as the denominator in our next PE calculation. With 109.04 as the numerator (as of 10/1/2024), the calculation is then 109.04 / 19.72 = 5.5 as the JAZZ PE ratio as of 10/1/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on JAZZ or any other given stock, valuation analysis for JAZZ can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Jazz Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for JAZZ. Thanks for visiting, and the next time you need to research JAZZ Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.